A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults
James J. Kobie, Wilton B. Williams, William O Hahn, Paul T. Edlefsen et autres
us (code pays fourni par la source)
0 citations
medRxiv